{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:29:21Z","timestamp":1793982561312,"version":"4.8.0"},"reference-count":237,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2020,11,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>A transcriptional regulatory nuclear factor kappa B (NF-&amp;#954;B) protein is a modulator of cellular biological activity via binding to a promoter region in the nucleus and transcribing various protein genes. The recent research implicated the intensive role of nuclear factor kappa B (NF-&amp;#954;B) in diseases like autoimmune disorder, inflammatory, cardiovascular and neurodegenerative diseases. Therefore, targeting the nuclear factor kappa B (NF-&amp;#954;B) protein offers a new opportunity as a therapeutic approach. Activation of I\u03baB kinase\/NF-&amp;#954;B signaling pathway leads to the development of various pathological conditions in human beings, such as neurodegenerative, inflammatory disorders, autoimmune diseases, and cancer. Therefore, the transcriptional activity of I&amp;#954;B kinase\/NF- &amp;#954;B is strongly regulated at various cascade pathways. The nuclear factor NF-kB pathway plays a major role in the expression of pro-inflammatory genes, including cytokines, chemokines, and adhesion molecules. In response to the diverse stimuli, the cytosolic sequestered NF-&amp;#954;B in an inactivated form by binding with an inhibitor molecule protein (IkB) gets phosphorylated and translocated into the nucleus further transcribing various genes necessary for modifying various cellular functions. The various researches confirmed the role of different family member proteins of NF-&amp;#954;B implicated in expressing various genes products and mediating various cellular cascades. MicroRNAs, as regulators of NF- &amp;#954;B microRNAs play important roles in the regulation of the inflammatory process. Therefore, the inhibitor of NF-&amp;#954;B and its family members plays a novel therapeutic target in preventing various diseases. Regulation of NF- &amp;#954;B signaling pathway may be a safe and effective treatment strategy for various disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570159x18666200207120949","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T08:16:36Z","timestamp":1581063396000},"page":"918-935","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":300,"title":["Role of Nuclear Factor Kappa B (NF-\u03baB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach"],"prefix":"10.2174","volume":"18","author":[{"given":"Shareen","family":"Singh","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1745-7254.2007.00741.x","volume":"28","author":"Qin Z.H.","year":"2007","unstructured":"Qin Z.H.; Tao L.Y.; Chen X.; Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. Acta Pharmacol Sin 2007,28(12),1859-1872","journal-title":"Acta Pharmacol Sin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"Chen C.H.","year":"2012","unstructured":"Chen C.H.; Zhou W.; Liu S.; Deng Y.; Cai F.; Tone M.; Tone Y.; Tong Y.; Song W.; Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 2012,15(1),77-90","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1517\/14728222.11.2.123","volume":"11","author":"Camandola S.","year":"2007","unstructured":"Camandola S.; Mattson M.P.; NF-\u03ba B as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets 2007,11(2),123-132","journal-title":"Expert Opin Ther Targets"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0098-2997(93)90004-W","volume":"14","author":"Kaltschmidt B.","year":"1993","unstructured":"Kaltschmidt B.; Baeuerle P.A.; Kaltschmidt C.; Potential involvement of the transcription factor NF-\u03ba B in neurological disorders. Mol Aspects Med 1993,14(3),171-190","journal-title":"Mol Aspects Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","volume":"20","author":"O\u2019Neill L.A.","year":"1997","unstructured":"O\u2019Neill L.A.; Kaltschmidt C.; NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997,20(6),252-258","journal-title":"Trends Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0092-8674(95)90506-5","volume":"80","author":"Thanos D.","year":"1995","unstructured":"Thanos D.; Maniatis T.; NF-\u03ba B: a lesson in family values. Cell 1995,80(4),529-532","journal-title":"Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","volume":"18","author":"Karin M.","year":"1999","unstructured":"Karin M.; How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999,18(49),6867-6874","journal-title":"Oncogene"},{"key":"ref=8","first-page":"519","volume":"90","author":"Tripathi P.","year":"2006","unstructured":"Tripathi P.; Aggarwal A.; NF-kB transcription factor: a key player in the generation of immune response. Curr Sci 2006,90(4),519","journal-title":"Curr Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcb.1144","volume":"82","author":"Cornwell W.D.","year":"2001","unstructured":"Cornwell W.D.; Kirkpatrick R.B.; Cactus-independent nuclear translocation of Drosophila RELISH. J Cell Biochem 2001,82(1),22-37","journal-title":"J Cell Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1128\/MCB.21.4.1024-1035.2001","volume":"21","author":"Heissmeyer V.","year":"2001","unstructured":"Heissmeyer V.; Krappmann D.; Hatada E.N.; Scheidereit C.; Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Mol Cell Biol 2001,21(4),1024-1035","journal-title":"Mol Cell Biol"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"Oeckinghaus A.","year":"2009","unstructured":"Oeckinghaus A.; Ghosh S.; The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009,1(4)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"21091","DOI":"10.1074\/jbc.M500754200","volume":"280","author":"Gao Z.","year":"2005","unstructured":"Gao Z.; Chiao P.; Zhang X.; Zhang X.; Lazar M.A.; Seto E.; Young H.A.; Ye J.; Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem 2005,280(22),21091-21098","journal-title":"J Biol Chem"},{"key":"ref=13","first-page":"4540","volume":"281","author":"Gao Z.","year":"2006","unstructured":"Gao Z.; He Q.; Peng B.; Chiao P.; Ye J.; Regulation of nuclear translocation of HDAC3 by IkBalpha is required for TNF-inhibition of PPARgamma function. J Biochem 2006,281(7),4540-4547","journal-title":"J Biochem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1038\/sj.emboj.7601899","volume":"26","author":"Barr\u00e9 B.","year":"2007","unstructured":"Barr\u00e9 B.; Perkins N.D.; A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J 2007,26(23),4841-4855","journal-title":"EMBO J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biomedicines6020043","volume":"6","author":"Courtois G.","year":"2018","unstructured":"Courtois G.; Fauvarque M.O.; The many roles of ubiquitin in NF-\u03baB signaling. Biomedicines 2018,6(2),43","journal-title":"Biomedicines"},{"key":"ref=16","first-page":"881","volume":"10","author":"Wu Y.","year":"2018","unstructured":"Wu Y.; Kang J.; Zhang L.; Liang Z.; Tang X.; Yan Y.; Qian H.; Zhang X.; Xu W.; Mao F.; Ubiquitination regulation of inflammatory responses through NF-\u03baB pathway. Am J Transl Res 2018,10(3),881-891","journal-title":"Am J Transl Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"Gilmore T.D.","year":"2006","unstructured":"Gilmore T.D.; Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006,25(51),6680-6684","journal-title":"Oncogene"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"Perkins N.D.","year":"2007","unstructured":"Perkins N.D.; Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007,8(1),49-62","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"Shih R.H.","year":"2015","unstructured":"Shih R.H.; Wang C.Y.; Yang C.M.; NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 2015,8,77","journal-title":"Front Mol Neurosci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/onc.2013.64","volume":"33","author":"Kendellen M.F.","year":"2014","unstructured":"Kendellen M.F.; Bradford J.W.; Lawrence C.L.; Clark K.S.; Baldwin A.S.; Canonical and non-canonical NF-\u03baB signaling promotes breast cancer tumor-initiating cells. Oncogene 2014,33(10),1297-1305","journal-title":"Oncogene"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1007\/s00018-008-8064-8","volume":"65","author":"Verstrepen L.","year":"2008","unstructured":"Verstrepen L.; Bekaert T.; Chau T.L.; Tavernier J.; Chariot A.; Beyaert R.; TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 2008,65(19),2964-2978","journal-title":"Cell Mol Life Sci"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"Isra\u00ebl A.","year":"2010","unstructured":"Isra\u00ebl A.; The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010,2(3)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"e00415","DOI":"10.1128\/MCB.00415-18","volume":"39","author":"Verma S.","year":"2019","unstructured":"Verma S.; De Jesus P.; Chanda S.K.; Verma I.M.; SNW1, a Novel transcriptional regulator of the NF-\u03baB pathway. Mol Cell Biol 2019,39(3),e00415-e00418","journal-title":"Mol Cell Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/ars.1999.1.2-129","volume":"1","author":"Kaltschmidt B.","year":"1999","unstructured":"Kaltschmidt B.; Sparna T.; Kaltschmidt C.; Activation of NF-\u03ba B by reactive oxygen intermediates in the nervous system. Antioxid Redox Signal 1999,1(2),129-144","journal-title":"Antioxid Redox Signal"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"Ghosh A.","year":"2007","unstructured":"Ghosh A.; Roy A.; Liu X.; Kordower J.H.; Mufson E.J.; Hartley D.M.; Ghosh S.; Mosley R.L.; Gendelman H.E.; Pahan K.; Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 2007,104(47),18754-18759","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501292","volume":"2","author":"Friedmann-Morvinski D.","year":"2016","unstructured":"Friedmann-Morvinski D.; Narasimamurthy R.; Xia Y.; Myskiw C.; Soda Y.; Verma I.M.; Targeting NF-\u03baB in glioblastoma: A therapeutic approach. Sci Adv 2016,2(1)","journal-title":"Sci Adv"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/JIR.S137606","volume":"11","author":"Negroni A.","year":"2018","unstructured":"Negroni A.; Pierdomenico M.; Cucchiara S.; Stronati L.; NOD2 and inflammation: current insights. J Inflamm Res 2018,11,49-60","journal-title":"J Inflamm Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.3390\/biom5043087","volume":"5","author":"Ahmed A.U.","year":"2015","unstructured":"Ahmed A.U.; Williams B.R.; Hannigan G.E.; Transcriptional activation of inflammatory genes: mechanistic insight into selectivity and diversity. Biomolecules 2015,5(4),3087-3111","journal-title":"Biomolecules"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrmicro2539","volume":"9","author":"Rahman M.M.","year":"2011","unstructured":"Rahman M.M.; McFadden G.; Modulation of NF-\u03baB signalling by microbial pathogens. Nat Rev Microbiol 2011,9(4),291-306","journal-title":"Nat Rev Microbiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1568010023344706","volume":"1","author":"Chen F.","year":"2002","unstructured":"Chen F.; Demers L.M.; Shi X.; Upstream signal transduction of NF-kappaB activation. Curr Drug Targets Inflamm Allergy 2002,1(2),137-149","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-2094-5-7","volume":"5","author":"Shaftel S.S.","year":"2008","unstructured":"Shaftel S.S.; Griffin W.S.T.; O\u2019Banion M.K.; The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008,5(1),7","journal-title":"J Neuroinflammation"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1007\/s12035-016-9988-x","volume":"54","author":"Stojakovic A.","year":"2017","unstructured":"Stojakovic A.; Paz-Filho G.; Arcos-Burgos M.; Licinio J.; Wong M.L.; Mastronardi C.A.; Role of the IL-1 pathway in dopaminergic neurodegeneration and decreased voluntary movement. Mol Neurobiol 2017,54(6),4486-4495","journal-title":"Mol Neurobiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fneur.2017.00244","volume":"8","author":"Garcia J.M.","year":"2017","unstructured":"Garcia J.M.; Stillings S.A.; Leclerc J.L.; Phillips H.; Edwards N.J.; Robicsek S.A.; Hoh B.L.; Blackburn S.; Dor\u00e9 S.; Role of interleukin-10 in acute brain injuries. Front Neurol 2017,8,244","journal-title":"Front Neurol"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6039171","volume":"2018","author":"Costantini E.","year":"2018","unstructured":"Costantini E.; D\u2019Angelo C.; Reale M.; The role of immunosenescence in neurodegenerative diseases. Mediators Inflamm 2018,2018","journal-title":"Mediators Inflamm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fcell.2019.00313","volume":"7","author":"Jung Y.J.","year":"2019","unstructured":"Jung Y.J.; Tweedie D.; Scerba M.T.; Greig N.H.; Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments. Front Cell Dev Biol 2019,7,313","journal-title":"Front Cell Dev Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"Glass C.K.","year":"2010","unstructured":"Glass C.K.; Saijo K.; Winner B.; Marchetto M.C.; Gage F.H.; Mechanisms underlying inflammation in neurodegeneration. Cell 2010,140(6),918-934","journal-title":"Cell"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20041674","volume":"201","author":"Krumbholz M.","year":"2005","unstructured":"Krumbholz M.; Theil D.; Derfuss T.; Rosenwald A.; Schrader F.; Monoranu C.M.; Kalled S.L.; Hess D.M.; Serafini B.; Aloisi F.; Wekerle H.; Hohlfeld R.; Meinl E.; BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005,201(2),195-200","journal-title":"J Exp Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.seizure.2017.03.016","volume":"48","author":"Ma L.","year":"2017","unstructured":"Ma L.; Li R.; Huang H.; Yuan J.; Ou S.; Xu T.; Yu X.; Liu X.; Chen Y.; Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model. Seizure 2017,48,79-88","journal-title":"Seizure"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.molcel.2008.03.017","volume":"30","author":"O\u2019Dea E.L.","year":"2008","unstructured":"O\u2019Dea E.L.; Kearns J.D.; Hoffmann A.; UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell 2008,30(5),632-641","journal-title":"Mol Cell"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jphotobiol.2017.05.018","volume":"172","author":"Verma A.","year":"2017","unstructured":"Verma A.; Kushwaha H.N.; Srivastava A.K.; Srivastava S.; Jamal N.; Srivastava K.; Ray R.S.; Piperine attenuates UV-R induced cell damage in human keratinocytes via NF-kB, Bax\/Bcl-2 pathway: An application for photoprotection. J Photochem Photobiol B 2017,172,139-148","journal-title":"J Photochem Photobiol B"},{"key":"ref=41","author":"Liu L.","unstructured":"Liu L.; Hui L.; Zhang Z.Z.; Activation of JNK\/Bim\/Bax pathway in UV-induced apoptosis. International Society for Optics and Photonics. In: Biophotonics and Immune Responses VI; 2011; p. 7900, 79000I."},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/jrr\/rrs036","volume":"53","author":"Begum N.","year":"2012","unstructured":"Begum N.; Wang B.; Mori M.; Vares G.; Does ionizing radiation influence Alzheimer\u2019s disease risk? J Radiat Res (Tokyo) 2012,53(6),815-822","journal-title":"J Radiat Res (Tokyo)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fnmol.2017.00339","volume":"10","author":"Li Y.","year":"2017","unstructured":"Li Y.; Jiao Q.; Xu H.; Du X.; Shi L.; Jia F.; Jiang H.; Biometal dyshomeostasis and toxic metal accumulations in the development of Alzheimer\u2019s disease. Front Mol Neurosci 2017,10,339","journal-title":"Front Mol Neurosci"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4350965]","volume":"2016","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Wang X.; Vikash V.; Ye Q.; Wu D.; Liu Y.; Dong W.; ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev 2016,2016","journal-title":"Oxid Med Cell Longev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3892\/ijmm.2017.2962","volume":"39","author":"Sun J.","year":"2017","unstructured":"Sun J.; Nan G.; The extracellular signal-regulated kinase 1\/2 pathway in neurological diseases: A potential therapeutic target. (Review). Int J Mol Med 2017,39(6),1338-1346","journal-title":"Int J Mol Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/molecules22081287","volume":"22","author":"Lee J.K.","year":"2017","unstructured":"Lee J.K.; Kim N.J.; Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease. Molecules 2017,22(8),1287","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.4049\/jimmunol.162.4.1889","volume":"162","author":"Choi C.","year":"1999","unstructured":"Choi C.; Park J.Y.; Lee J.; Lim J.H.; Shin E.C.; Ahn Y.S.; Kim C.H.; Kim S.J.; Kim J.D.; Choi I.S.; Choi I.H.; Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-\u03b1, or IFN-\u03b3. J Immunol 1999,162(4),1889-1895","journal-title":"J Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-015-0448-8","volume":"12","author":"Vuong B.","year":"2015","unstructured":"Vuong B.; Hogan-Cann A.D.; Alano C.C.; Stevenson M.; Chan W.Y.; Anderson C.M.; Swanson R.A.; Kauppinen T.M.; NF-\u03baB transcriptional activation by TNF\u03b1 requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1. J Neuroinflammation 2015,12(1),229","journal-title":"J Neuroinflammation"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2006.02.001","volume":"174","author":"Yin D.","year":"2006","unstructured":"Yin D.; Woodruff M.; Zhang Y.; Whaley S.; Miao J.; Ferslew K.; Zhao J.; Stuart C.; Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD\/P53 and anti-apoptotic PI3K\/Akt\/NF-kappaB pathways. J Neuroimmunol 2006,174(1-2),101-107","journal-title":"J Neuroimmunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12264-007-0046-6","volume":"23","author":"Yang L.","year":"2007","unstructured":"Yang L.; Tao L.Y.; Chen X.P.; Roles of NF-kappaB in central nervous system damage and repair. Neurosci Bull 2007,23(5),307-313","journal-title":"Neurosci Bull"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/etm.2011.382","volume":"3","author":"Kinaci M.K.","year":"2012","unstructured":"Kinaci M.K.; Erkasap N.; Kucuk A.; Koken T.; Tosun M.; Effects of quercetin on apoptosis, NF-\u03baB and NOS gene expression in renal ischemia\/reperfusion injury. Exp Ther Med 2012,3(2),249-254","journal-title":"Exp Ther Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3892\/mmr.2019.10537","volume":"20","author":"Jia G.","year":"2019","unstructured":"Jia G.; Zhang Y.; Li W.; Dai H.; Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, anti-neuroinflammatory and anti-apoptotic properties. Mol Med Rep 2019,20(4),3433-3439","journal-title":"Mol Med Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1242\/dev.01702","volume":"132","author":"Gutierrez H.","year":"2005","unstructured":"Gutierrez H.; Hale V.A.; Dolcet X.; Davies A.; NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development 2005,132(7),1713-1726","journal-title":"Development"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tins.2011.03.001","volume":"34","author":"Gutierrez H.","year":"2011","unstructured":"Gutierrez H.; Davies A.M.; Regulation of neural process growth, elaboration and structural plasticity by NF-\u03baB. Trends Neurosci 2011,34(6),316-325","journal-title":"Trends Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"Mattson M.P.","year":"2001","unstructured":"Mattson M.P.; Camandola S.; NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001,107(3),247-254","journal-title":"J Clin Invest"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1073858412444007","volume":"19","author":"Mincheva-Tasheva S.","year":"2013","unstructured":"Mincheva-Tasheva S.; Soler R.M.; NF-\u03baB signaling pathways: role in nervous system physiology and pathology. Neuroscientist 2013,19(2),175-194","journal-title":"Neuroscientist"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnmol.2016.00118","volume":"9","author":"Snow W.M.","year":"2016","unstructured":"Snow W.M.; Albensi B.C.; Neuronal gene targets of NF-\u03baB and their dysregulation in Alzheimer\u2019s disease. Front Mol Neurosci 2016,9,118","journal-title":"Front Mol Neurosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4103\/1673-5374.131572","volume":"9","author":"Engelmann C.","year":"2014","unstructured":"Engelmann C.; Weih F.; Haenold R.; Role of nuclear factor kappa B in central nervous system regeneration. Neural Regen Res 2014,9(7),707-711","journal-title":"Neural Regen Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","volume":"13","author":"Mattson M.P.","year":"2006","unstructured":"Mattson M.P.; Meffert M.K.; Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 2006,13(5),852-860","journal-title":"Cell Death Differ"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","volume":"10","author":"Dresselhaus E.C.","year":"2019","unstructured":"Dresselhaus E.C.; Meffert M.K.; Cellular specificity of NF-kappaB function in the nervous system. Front Immunol 2019,10,1043","journal-title":"Front Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.pharep.2018.05.002","volume":"70","author":"Motyl J.","year":"2018","unstructured":"Motyl J.; Strosznajder J.B.; Sphingosine kinase 1\/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson\u2019s disease. Pharmacol Rep 2018,70(5),1010-1014","journal-title":"Pharmacol Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/sita.200500070","volume":"5","author":"Strozyk E.","year":"2005","unstructured":"Strozyk E.; Kulms D.; NF\u03baB: cell survival or cell death? Signal Transduct 2005,5(6),334-349","journal-title":"Signal Transduct"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11481-013-9517-x","volume":"9","author":"Pozniak P.D.","year":"2014","unstructured":"Pozniak P.D.; White M.K.; Khalili K.; TNF-\u03b1\/NF-\u03baB signaling in the CNS: possible connection to EPHB2. J Neuroimmune Pharmacol 2014,9(2),133-141","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"Sedger L.M.","year":"2014","unstructured":"Sedger L.M.; McDermott M.F.; TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev 2014,25(4),453-472","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"Karin M.","year":"2002","unstructured":"Karin M.; Lin A.; NF-kappaB at the crossroads of life and death. Nat Immunol 2002,3(3),221-227","journal-title":"Nat Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.bbapap.2010.05.002","volume":"1804","author":"Yi J.","year":"2010","unstructured":"Yi J.; Luo J.; SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 2010,1804(8),1684-1689","journal-title":"Biochim Biophys Acta"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12011-018-1535-3","volume":"190","author":"Nkpaa K.W.","year":"2019","unstructured":"Nkpaa K.W.; Adedara I.A.; Amadi B.A.; Wegwu M.O.; Farombi E.O.; Ethanol via Regulation of NF-\u03baB\/p53 Signaling Pathway Increases Manganese-Induced Inflammation and Apoptosis in Hypothalamus of Rats. Biol Trace Elem Res 2019,190(1),101-108","journal-title":"Biol Trace Elem Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00204-019-02424-7","volume":"93","author":"Park A.","year":"2019","unstructured":"Park A.; Koh H.C.; NF-\u03baB\/mTOR-mediated autophagy can regulate diquat-induced apoptosis. Arch Toxicol 2019,93(5),1239-1253","journal-title":"Arch Toxicol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.2174\/1381612825666190717110932","volume":"25","author":"Pourhanifeh M.H.","year":"2019","unstructured":"Pourhanifeh M.H.; Shafabakhsh R.; Reiter R.J.; Asemi Z.; The Effect of resveratrol on neurodegenerative disorders: possible protective actions against autophagy, apoptosis, inflammation and oxidative stress. Curr Pharm Des 2019,25(19),2178-2191","journal-title":"Curr Pharm Des"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bbrc.2005.03.149","volume":"331","author":"Culmsee C.","year":"2005","unstructured":"Culmsee C.; Mattson M.P.; p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005,331(3),761-777","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/sj.cdd.4400463","volume":"6","author":"Grilli M.","year":"1999","unstructured":"Grilli M.; Memo M.; Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ 1999,6(1),22-27","journal-title":"Cell Death Differ"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12974-019-1394-7","volume":"16","author":"Karova K.","year":"2019","unstructured":"Karova K.; Wainwright J.V.; Machova-Urdzikova L.; Pisal R.V.; Schmidt M.; Jendelova P.; Jhanwar-Uniyal M.; Transplantation of neural precursors generated from spinal progenitor cells reduces inflammation in spinal cord injury via NF-\u03baB pathway inhibition. J Neuroinflammation 2019,16(1),12","journal-title":"J Neuroinflammation"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","volume":"56","author":"Swarbrick S.","year":"2019","unstructured":"Swarbrick S.; Wragg N.; Ghosh S.; Stolzing A.; Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease. Mol Neurobiol 2019,56(9),6156-6167","journal-title":"Mol Neurobiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/nu11030648","volume":"11","author":"Muhammad T.","year":"2019","unstructured":"Muhammad T.; Ikram M.; Ullah R.; Rehman S.U.; Kim M.O.; Hesperetin, a citrus flavonoid, attenuates lps-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4\/NF-\u03baB signaling. Nutrients 2019,11(3),648","journal-title":"Nutrients"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2202-13-115","volume":"13","author":"Hu K.","year":"2012","unstructured":"Hu K.; Xie Y.Y.; Zhang C.; Ouyang D.S.; Long H.Y.; Sun D.N.; Long L.L.; Feng L.; Li Y.; Xiao B.; MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 2012,13(1),115","journal-title":"BMC Neurosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"24895","DOI":"10.3390\/ijms161024895","volume":"16","author":"Hu Y.","year":"2015","unstructured":"Hu Y.; Deng H.; Xu S.; Zhang J.; MicroRNAs regulate mitochondrial function in cerebral ischemia-reperfusion injury. Int J Mol Sci 2015,16(10),24895-24917","journal-title":"Int J Mol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/10715762.2019.1608982","volume":"53","author":"Savari F.","year":"2019","unstructured":"Savari F.; Badavi M.; Rezaie A.; Gharib-Naseri M.K.; Mard S.A.; Evaluation of the therapeutic potential effect of Fas receptor gene knockdown in experimental model of non-alcoholic steatohepatitis. Free Radic Res 2019,53(5),486-496","journal-title":"Free Radic Res"},{"key":"ref=78","first-page":"1003","volume":"1","author":"Kempuraj D.","year":"2016","unstructured":"Kempuraj D.; Thangavel R.; Natteru P.A.; Selvakumar G.P.; Saeed D.; Zahoor H.; Zaheer S.; Iyer S.S.; Zaheer A.; Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine 2016,1(1),1003","journal-title":"J Neurol Neurosurg Spine"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.32794\/mr11250011","volume":"2","author":"Tan D.X.","year":"2019","unstructured":"Tan D.X.; Reiter R.J.; Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res 2019,2(1),44-66","journal-title":"Melatonin Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jnr.10404","volume":"70","author":"Borg J.","year":"2002","unstructured":"Borg J.; London J.; Copper\/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res 2002,70(2),180-189","journal-title":"J Neurosci Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.gendis.2019.04.002","volume":"6","author":"Sun L.","year":"2019","unstructured":"Sun L.; Guo Y.; He P.; Xu X.; Zhang X.; Wang H.; Tang T.; Zhou W.; Xu P.; Xie P.; Genome-wide profiling of long noncoding RNA expression patterns and CeRNA analysis in mouse cortical neurons infected with different strains of borna disease virus. Genes Dis 2019,6(2),147-158","journal-title":"Genes Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"Cimmino A.","year":"2005","unstructured":"Cimmino A.; Calin G.A.; Fabbri M.; Iorio M.V.; Ferracin M.; Shimizu M.; Wojcik S.E.; Aqeilan R.I.; Zupo S.; Dono M.; Rassenti L.; Alder H.; Volinia S.; Liu C.G.; Kipps T.J.; Negrini M.; Croce C.M.; miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005,102(39),13944-13949","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"Wang X.","year":"2009","unstructured":"Wang X.; Liu P.; Zhu H.; Xu Y.; Ma C.; Dai X.; Huang L.; Liu Y.; Zhang L.; Qin C.; miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull 2009,80(4-5),268-273","journal-title":"Brain Res Bull"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mito.2011.09.001","volume":"12","author":"Ouyang Y.B.","year":"2012","unstructured":"Ouyang Y.B.; Lu Y.; Yue S.; Giffard R.G.; miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 2012,12(2),213-219","journal-title":"Mitochondrion"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.92","volume":"5","author":"Chen Q.","year":"2014","unstructured":"Chen Q.; Xu J.; Li L.; Li H.; Mao S.; Zhang F.; Zen K.; Zhang C.Y.; Zhang Q.; MicroRNA-23a\/b and microRNA-27a\/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis 2014,5(3)","journal-title":"Cell Death Dis"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3892\/mmr.2019.9904","volume":"19","author":"Xu Z.","year":"2019","unstructured":"Xu Z.; Zhang K.; Wang Q.; Zheng Y.; MicroRNA124 improves functional recovery and suppresses Baxdependent apoptosis in rats following spinal cord injury. Mol Med Rep 2019,19(4),2551-2560","journal-title":"Mol Med Rep"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"Blokhuis A.M.","year":"2013","unstructured":"Blokhuis A.M.; Groen E.J.; Koppers M.; van den Berg L.H.; Pasterkamp R.J.; Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013,125(6),777-794","journal-title":"Acta Neuropathol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"e00155","DOI":"10.1128\/MCB.00155-18","volume":"38","author":"Fomin V.","year":"2018","unstructured":"Fomin V.; Richard P.; Hoque M.; Li C.; Gu Z.; Fissore-O\u2019Leary M.; Tian B.; Prives C.; Manley J.L.; The C9ORF72 gene, implicated in ALS\/FTD, encodes a protein that functions in control of endothelin and glutamate signaling. Mol Cell Biol 2018,38(22),e00155-e18","journal-title":"Mol Cell Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1046\/j.1471-4159.2002.01232.x","volume":"83","author":"Casciati A.","year":"2002","unstructured":"Casciati A.; Ferri A.; Cozzolino M.; Celsi F.; Nencini M.; Rotilio G.; Carr\u00ec M.T.; Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J Neurochem 2002,83(5),1019-1029","journal-title":"J Neurochem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2014.03.005","volume":"270","author":"Prell T.","year":"2014","unstructured":"Prell T.; Lautenschl\u00e4ger J.; Weidemann L.; Ruhmer J.; Witte O.W.; Grosskreutz J.; Endoplasmic reticulum stress is accompanied by activation of NF-\u03baB in amyotrophic lateral sclerosis. J Neuroimmunol 2014,270(1-2),29-36","journal-title":"J Neuroimmunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.20517\/2347-8659.2017.47","volume":"5","author":"Dong Y.","year":"2018","unstructured":"Dong Y.; Chen Y.; The role of ubiquitinated TDP-43 in amyotrophic lateral sclerosis. Neuroimmunol Neuroinflamm 2018,5,5","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"Frakes A.E.","year":"2014","unstructured":"Frakes A.E.; Ferraiuolo L.; Haidet-Phillips A.M.; Schmelzer L.; Braun L.; Miranda C.J.; Ladner K.J.; Bevan A.K.; Foust K.D.; Godbout J.P.; Popovich P.G.; Guttridge D.C.; Kaspar B.K.; Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis. Neuron 2014,81(5),1009-1023","journal-title":"Neuron"},{"key":"ref=93","first-page":"413","author":"Cereda C.","year":"2012","unstructured":"Cereda C.; Gagliardi S.; Cova E.; Diamanti L.; Ceroni M.; The role of TNF-Alpha in ALS: new hypotheses for future therapeutic approaches. Amyotroph Lateral Scler 2012,413-436","journal-title":"Amyotroph Lateral Scler"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"Swarup V.","year":"2011","unstructured":"Swarup V.; Phaneuf D.; Dupr\u00e9 N.; Petri S.; Strong M.; Kriz J.; Julien J.P.; Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways. J Exp Med 2011,208(12),2429-2447","journal-title":"J Exp Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1038\/s41598-019-41040-4","volume":"9","author":"Ajmone-Cat M.A.","year":"2019","unstructured":"Ajmone-Cat M.A.; Onori A.; Toselli C.; Stronati E.; Morlando M.; Bozzoni I.; Monni E.; Kokaia Z.; Lupo G.; Minghetti L.; Biagioni S.; Cacci E.; Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci Rep 2019,9(1),4572","journal-title":"Sci Rep"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2051-5960-2-37","volume":"2","author":"Ohta Y.","year":"2014","unstructured":"Ohta Y.; Tremblay C.; Schneider J.A.; Bennett D.A.; Calon F.; Julien J.P.; Interaction of transactive response DNA binding protein 43 with nuclear factor \u03baB in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun 2014,2(1),37","journal-title":"Acta Neuropathol Commun"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11064-018-2556-1","volume":"43","author":"Ohuchi K.","year":"2018","unstructured":"Ohuchi K.; Ono Y.; Joho M.; Tsuruma K.; Ogami S.; Yamane S.; Funato M.; Kaneko H.; Nakamura S.; Hara H.; Shimazawa M.; A docosahexaenoic acid-derived pro-resolving agent, Maresin 1, protects motor neuron cells death. Neurochem Res 2018,43(7),1413-1423","journal-title":"Neurochem Res"},{"key":"ref=98","author":"Rinchetti P.","unstructured":"Rinchetti P.; Rizzuti M.; Faravelli I.; Corti S.; MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis Mol neuro, 2018, 55(3), 2617-30","journal-title":"MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis Mol neuro, 2018, 55(3), 2617-30"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-018-1204-1","volume":"66","author":"Dardiotis E.","year":"2018","unstructured":"Dardiotis E.; Aloizou A.M.; Siokas V.; Patrinos G.P.; Deretzi G.; Mitsias P.; Aschner M.; Tsatsakis A.; The role of microRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci 2018,66(4),617-628","journal-title":"J Mol Neurosci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fnagi.2017.00120","volume":"9","author":"Shah S.Z.A.","year":"2017","unstructured":"Shah S.Z.A.; Zhao D.; Hussain T.; Yang L.; The role of unfolded protein response and mitogen-activated protein kinase signaling in neurodegenerative diseases with special focus on prion diseases. Front Aging Neurosci 2017,9,120","journal-title":"Front Aging Neurosci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1099\/vir.0.83622-0","volume":"89","author":"Julius C.","year":"2008","unstructured":"Julius C.; Heikenwalder M.; Schwarz P.; Marcel A.; Karin M.; Prinz M.; Pasparakis M.; Aguzzi A.; Prion propagation in mice lacking central nervous system NF-kappaB signalling. J Gen Virol 2008,89(Pt 6),1545-1550","journal-title":"J Gen Virol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nri3553","volume":"13","author":"Aguzzi A.","year":"2013","unstructured":"Aguzzi A.; Nuvolone M.; Zhu C.; The immunobiology of prion diseases. Nat Rev Immunol 2013,13(12),888-902","journal-title":"Nat Rev Immunol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/1874609812666190111100205","volume":"11","author":"Prasad K.N.","year":"2019","unstructured":"Prasad K.N.; Bondy S.C.; Oxidative and inflammatory events in prion diseases: can they be therapeutic targets? Curr Aging Sci 2019,11(4),216-225","journal-title":"Curr Aging Sci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/v11010065","volume":"11","author":"Carroll J.A.","year":"2019","unstructured":"Carroll J.A.; Chesebro B.; Neuroinflammation, microglia, and cell-association during prion disease. Viruses 2019,11(1),65","journal-title":"Viruses"},{"key":"ref=105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003652","volume":"3","author":"Saba R.","year":"2008","unstructured":"Saba R.; Goodman C.D.; Huzarewich R.L.; Robertson C.; Booth S.A.; A miRNA signature of prion induced neurodegeneration. PLoS One 2008,3(11)","journal-title":"PLoS One"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnagi.2018.00220","volume":"10","author":"Kanata E.","year":"2018","unstructured":"Kanata E.; Th\u00fcne K.; Xanthopoulos K.; Ferrer I.; Dafou D.; Zerr I.; Sklaviadis T.; Llorens F.; MicroRNA alterations in the brain and body fluids of humans and animal prion disease models: current status and perspectives. Front Aging Neurosci 2018,10,220","journal-title":"Front Aging Neurosci"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030832","volume":"7","author":"Saba R.","year":"2012","unstructured":"Saba R.; Gushue S.; Huzarewich R.L.; Manguiat K.; Medina S.; Robertson C.; Booth S.A.; MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012,7(2)","journal-title":"PLoS One"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1189\/jlb.1102521","volume":"74","author":"Bacot S.M.","year":"2003","unstructured":"Bacot S.M.; Lenz P.; Frazier-Jessen M.R.; Feldman G.M.; Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells. J Leukoc Biol 2003,74(1),118-125","journal-title":"J Leukoc Biol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1111\/j.1462-5822.2007.00950.x","volume":"9","author":"Bourteele S.","year":"2007","unstructured":"Bourteele S.; Oesterle K.; Weinzierl A.O.; Paxian S.; Riemann M.; Schmid R.M.; Planz O.; Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol 2007,9(9),2202-2217","journal-title":"Cell Microbiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"18747","DOI":"10.1074\/jbc.M117.787283","volume":"292","author":"Wu G.R.","year":"2017","unstructured":"Wu G.R.; Mu T.C.; Gao Z.X.; Wang J.; Sy M.S.; Li C.Y.; Prion protein is required for tumor necrosis factor \u03b1 (TNF\u03b1)-triggered nuclear factor \u03baB (NF-\u03baB) signaling and cytokine production. J Biol Chem 2017,292(46),18747-18759","journal-title":"J Biol Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"Sawa A.","year":"1999","unstructured":"Sawa A.; Wiegand G.W.; Cooper J.; Margolis R.L.; Sharp A.H.; Lawler J.F.; Greenamyre J.T.; Snyder S.H.; Ross C.A.; Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 1999,5(10),1194-1198","journal-title":"Nat Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","volume":"19","author":"Marcora E.","year":"2010","unstructured":"Marcora E.; Kennedy M.B.; The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus. Hum Mol Genet 2010,19(22),4373-4384","journal-title":"Hum Mol Genet"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nature22489","volume":"545","author":"Martin D.D.O.","year":"2017","unstructured":"Martin D.D.O.; Hayden M.R.; Neurodegeneration: Role of repeats in protein clearance. Nature 2017,545(7652),33-34","journal-title":"Nature"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/19336896.2016.1176659","volume":"10","author":"Alexandrov A.I.","year":"2016","unstructured":"Alexandrov A.I.; Serpionov G.V.; Kushnirov V.V.; Ter-Avanesyan M.D.; Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. Prion 2016,10(3),221-227","journal-title":"Prion"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"5a","DOI":"10.1016\/j.bpj.2018.11.054","volume":"116","author":"Hatters D.M.","year":"2019","unstructured":"Hatters D.M.; Proteome Aggregation patterns under proteostasis stress as signatures for understanding Huntington\u2019s Disease. Biophys J 2019,116(3),5a","journal-title":"Biophys J"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neulet.2007.09.056","volume":"434","author":"Napolitano M.","year":"2008","unstructured":"Napolitano M.; Zei D.; Centonze D.; Palermo R.; Bernardi G.; Vacca A.; Calabresi P.; Gulino A.; NF-kB\/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington\u2019s disease. Neurosci Lett 2008,434(3),241-246","journal-title":"Neurosci Lett"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/jcmm.12748","volume":"20","author":"Turillazzi E.","year":"2016","unstructured":"Turillazzi E.; Neri M.; Cerretani D.; Cantatore S.; Frati P.; Moltoni L.; Busard\u00f2 F.P.; Pomara C.; Riezzo I.; Fineschi V.; Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kB. J Cell Mol Med 2016,20(4),601-612","journal-title":"J Cell Mol Med"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cns.13123","volume":"25","author":"Zhou B.","year":"2019","unstructured":"Zhou B.; Zuo Y.X.; Jiang R.T.; Astrocyte morphology: Diversity, plasticity, and role in neurological diseases. CNS Neurosci Ther 2019,25(6),665-673","journal-title":"CNS Neurosci Ther"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pbb.2018.08.010","volume":"176","author":"Zhou P.","year":"2019","unstructured":"Zhou P.; Du S.; Zhou L.; Sun Z.; Zhuo L.H.; He G.; Zhao Y.; Wu Y.; Zhang X.; Tetramethylpyrazine2'Osodium ferulate provides neuroprotection against neuroinflammation and brain injury in MCAO\/R rats by suppressing TLR-4\/NF-\u03baB signaling pathway. Pharmacol Biochem Behav 2019,176,33-42","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023837","volume":"6","author":"Ghose J.","year":"2011","unstructured":"Ghose J.; Sinha M.; Das E.; Jana N.R.; Bhattacharyya N.P.; Regulation of miR-146a by RelA\/NFkB and p53 in STHdh(Q111)\/Hdh(Q111) cells, a cell model of Huntington\u2019s disease. PLoS One 2011,6(8)","journal-title":"PLoS One"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-017-0742-x","volume":"12","author":"Chang K.H.","year":"2017","unstructured":"Chang K.H.; Wu Y.R.; Chen C.M.; Down-regulation of miR-9* in the peripheral leukocytes of Huntington\u2019s disease patients. Orphanet J Rare Dis 2017,12(1),185","journal-title":"Orphanet J Rare Dis"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrn.2017.92","volume":"18","author":"Paulson H.L.","year":"2017","unstructured":"Paulson H.L.; Shakkottai V.G.; Clark H.B.; Orr H.T.; Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat Rev Neurosci 2017,18(10),613-626","journal-title":"Nat Rev Neurosci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neuron.2010.08.013","volume":"68","author":"Li J.","year":"2010","unstructured":"Li J.; Gu X.; Ma Y.; Calicchio M.L.; Kong D.; Teng Y.D.; Yu L.; Crain A.M.; Vartanian T.K.; Pasqualini R.; Arap W.; Libermann T.A.; Snyder E.Y.; Sidman R.L.; Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-\u03baB signaling. Neuron 2010,68(1),45-60","journal-title":"Neuron"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/glia.23451","volume":"66","author":"Kim J.H.","year":"2018","unstructured":"Kim J.H.; Lukowicz A.; Qu W.; Johnson A.; Cvetanovic M.; Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Glia 2018,66(9),1972-1987","journal-title":"Glia"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fncel.2018.00509","volume":"12","author":"Mellesmoen A.","year":"2019","unstructured":"Mellesmoen A.; Sheeler C.; Ferro A.; Rainwater O.; Cvetanovic M.; Brain derived neurotrophic factor (BDNF) delays onset of pathogenesis in transgenic mouse model of spinocerebellar ataxia type 1 (SCA1). Front Cell Neurosci 2019,12,509","journal-title":"Front Cell Neurosci"},{"key":"ref=126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200013","volume":"13","author":"Ferro A.","year":"2018","unstructured":"Ferro A.; Qu W.; Lukowicz A.; Svedberg D.; Johnson A.; Cvetanovic M.; Inhibition of NF-\u03baB signaling in IKK\u03b2F\/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1. PLoS One 2018,13(7)","journal-title":"PLoS One"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2053-8871-1-7","volume":"1","author":"Koscianska E.","year":"2014","unstructured":"Koscianska E.; Krzyzosiak W.J.; Current understanding of the role of microRNAs in spinocerebellar ataxias. Cerebellum Ataxias 2014,1(1),7","journal-title":"Cerebellum Ataxias"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2017.08.003","volume":"108","author":"van der Stijl R.","year":"2017","unstructured":"van der Stijl R.; Withoff S.; Verbeek D.S.; Spinocerebellar ataxia: miRNAs expose biological pathways underlying pervasive Purkinje cell degeneration. Neurobiol Dis 2017,108,148-158","journal-title":"Neurobiol Dis"},{"key":"ref=129","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0534","author":"Zarouchlioti C.","unstructured":"Zarouchlioti C.; Parfitt D.A.; Li W.; Gittings L.M.; Cheetham M.E.; DNAJ Proteins in neurodegeneration: essential and protective factors Philos. Trans. R. Soc. Lond. B Biol. Sci., 2018, 373(1738), 20160534.","journal-title":"DNAJ Proteins in neurodegeneration: essential and protective factors"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/nn.2183","volume":"11","author":"Lee Y.","year":"2008","unstructured":"Lee Y.; Samaco R.C.; Gatchel J.R.; Thaller C.; Orr H.T.; Zoghbi H.Y.; miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008,11(10),1137-1139","journal-title":"Nat Neurosci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.nbd.2013.01.019","volume":"54","author":"Rodriguez-Lebron E.","year":"2013","unstructured":"Rodriguez-Lebron E.; Liu G.; Keiser M.; Behlke M.A.; Davidson B.L.; Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Neurobiol Dis 2013,54,456-463","journal-title":"Neurobiol Dis"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1093\/nar\/gks521","volume":"40","author":"Gantier M.P.","year":"2012","unstructured":"Gantier M.P.; Stunden H.J.; McCoy C.E.; Behlke M.A.; Wang D.; Kaparakis-Liaskos M.; Sarvestani S.T.; Yang Y.H.; Xu D.; Corr S.C.; Morand E.F.; Williams B.R.; A miR-19 regulon that controls NF-\u03baB signaling. Nucleic Acids Res 2012,40(16),8048-8058","journal-title":"Nucleic Acids Res"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/glia.22483","volume":"61","author":"Hutchison E.R.","year":"2013","unstructured":"Hutchison E.R.; Kawamoto E.M.; Taub D.D.; Lal A.; Abdelmohsen K.; Zhang Y.; Wood W.H.; Lehrmann E.; Camandola S.; Becker K.G.; Gorospe M.; Mattson M.P.; Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia 2013,61(7),1018-1028","journal-title":"Glia"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"Karch C.M.","year":"2015","unstructured":"Karch C.M.; Goate A.M.; Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 2015,77(1),43-51","journal-title":"Biol Psychiatry"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"Chen X.Q.","year":"2019","unstructured":"Chen X.Q.; Mobley W.C.; Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci 2019,13,659","journal-title":"Front Neurosci"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/dneu.22556","volume":"78","author":"Sun J.","year":"2018","unstructured":"Sun J.; Roy S.; The physical approximation of APP and BACE-1: A key event in alzheimer\u2019s disease pathogenesis. Dev Neurobiol 2018,78(3),340-347","journal-title":"Dev Neurobiol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"Oh S.B.","year":"2019","unstructured":"Oh S.B.; Kim M.S.; Park S.; Son H.; Kim S.Y.; Kim M.S.; Jo D.G.; Tak E.; Lee J.Y.; Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 2019,29(2),217-231","journal-title":"Brain Pathol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4236\/aad.2013.22008","volume":"2","author":"Pung L.","year":"2013","unstructured":"Pung L.; Wang X.; Li M.; Xue L.; The role of APP in Alzheimer\u2019s disease. Adv Alzheimer Dis 2013,2(02),60","journal-title":"Adv Alzheimer Dis"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Heneka M.T.","year":"2015","unstructured":"Heneka M.T.; Carson M.J.; El Khoury J.; Landreth G.E.; Brosseron F.; Feinstein D.L.; Jacobs A.H.; Wyss-Coray T.; Vitorica J.; Ransohoff R.M.; Herrup K.; Frautschy S.A.; Finsen B.; Brown G.C.; Verkhratsky A.; Yamanaka K.; Koistinaho J.; Latz E.; Halle A.; Petzold G.C.; Town T.; Morgan D.; Shinohara M.L.; Perry V.H.; Holmes C.; Bazan N.G.; Brooks D.J.; Hunot S.; Joseph B.; Deigendesch N.; Garaschuk O.; Boddeke E.; Dinarello C.A.; Breitner J.C.; Cole G.M.; Golenbock D.T.; Kummer M.P.; Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 2015,14(4),388-405","journal-title":"Lancet Neurol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"Heneka M.T.","year":"2018","unstructured":"Heneka M.T.; McManus R.M.; Latz E.; Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 2018,19(10),610-621","journal-title":"Nat Rev Neurosci"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"H\u00e9bert S.S.","year":"2009","unstructured":"H\u00e9bert S.S.; Horr\u00e9 K.; Nicola\u00ef L.; Bergmans B.; Papadopoulou A.S.; Delacourte A.; De Strooper B.; MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression. Neurobiol Dis 2009,33(3),422-428","journal-title":"Neurobiol Dis"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/jgmh.jgmh_33_17","volume":"5","author":"Sujeetha P.","year":"2018","unstructured":"Sujeetha P.; Cheerian J.; Basavaraju P.; Moorthi P.V.; Anand A.V.; The role of epigenetics in Alzheimer\u2019s disease. J Geri Ment Health 2018,5(2),94","journal-title":"J Geri Ment Health"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","volume":"50","author":"Zhao Y.","year":"2014","unstructured":"Zhao Y.; Bhattacharjee S.; Jones B.M.; Hill J.; Dua P.; Lukiw W.J.; Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 2014,50(1),97-106","journal-title":"Mol Neurobiol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"Walker L.","year":"2019","unstructured":"Walker L.; Stefanis L.; Attems J.; Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions. J Neurochem 2019,150(5),467-474","journal-title":"J Neurochem"},{"key":"ref=145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118449","volume":"567","author":"Gan L.","year":"2019","unstructured":"Gan L.; Li Z.; Lv Q.; Huang W.; Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. Int J Pharm 2019,567","journal-title":"Int J Pharm"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbi.2017.10.019","volume":"279","author":"Goes A.T.R.","year":"2018","unstructured":"Goes A.T.R.; Jesse C.R.; Antunes M.S.; Lobo Ladd F.V.; Lobo Ladd A.A.B.; Luchese C.; Paroul N.; Boeira S.P.; Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson\u2019s disease: Involvement of neuroinflammation and neurotrophins. Chem Biol Interact 2018,279,111-120","journal-title":"Chem Biol Interact"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2018.02.049","volume":"672","author":"Jiang X.","year":"2018","unstructured":"Jiang X.; Wang X.; Tuo M.; Ma J.; Xie A.; RAGE and its emerging role in the pathogenesis of Parkinson\u2019s disease. Neurosci Lett 2018,672,65-69","journal-title":"Neurosci Lett"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jcp.26865","volume":"234","author":"Hassanzadeh K.","year":"2018","unstructured":"Hassanzadeh K.; Rahimmi A.; Oxidative stress and neuroinflammation in the story of Parkinson\u2019s disease: Could targeting these pathways write a good ending? J Cell Physiol 2018,234(1),23-32","journal-title":"J Cell Physiol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"Asanuma M.","year":"2003","unstructured":"Asanuma M.; Miyazaki I.; Ogawa N.; Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 2003,5(3),165-176","journal-title":"Neurotox Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"Mi\u00f1ones-Moyano E.","year":"2011","unstructured":"Mi\u00f1ones-Moyano E.; Porta S.; Escaram\u00eds G.; Rabionet R.; Iraola S.; Kagerbauer B.; Espinosa-Parrilla Y.; Ferrer I.; Estivill X.; Mart\u00ed E.; MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function. Hum Mol Genet 2011,20(15),3067-3078","journal-title":"Hum Mol Genet"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jchemneu.2011.01.005","volume":"42","author":"Harraz M.M.","year":"2011","unstructured":"Harraz M.M.; Dawson T.M.; Dawson V.L.; MicroRNAs in Parkinson\u2019s disease. J Chem Neuroanat 2011,42(2),127-130","journal-title":"J Chem Neuroanat"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.drudis.2019.04.003","volume":"24","author":"Correddu D.","year":"2019","unstructured":"Correddu D.; Leung I.K.H.; Targeting mRNA translation in Parkinson\u2019s disease. Drug Discov Today 2019,24(6),1295-1303","journal-title":"Drug Discov Today"},{"key":"ref=153","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134361","volume":"708","author":"Mart\u00edn-Nieto J.","year":"2019","unstructured":"Mart\u00edn-Nieto J.; Uribe M.L.; Esteve-Rudd J.; Herrero M.T.; Campello L.; A role for DJ-1 against oxidative stress in the mammalian retina. Neurosci Lett 2019,708","journal-title":"Neurosci Lett"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","volume":"589","author":"Kabaria S.","year":"2015","unstructured":"Kabaria S.; Choi D.C.; Chaudhuri A.D.; Mouradian M.M.; Junn E.; Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson\u2019s disease. FEBS Lett 2015,589(3),319-325","journal-title":"FEBS Lett"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"Yao L.","year":"2019","unstructured":"Yao L.; Zhu Z.; Wu J.; Zhang Y.; Zhang H.; Sun X.; Qian C.; Wang B.; Xie L.; Zhang S.; Lu G.; MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 2019,33(7),8648-8665","journal-title":"FASEB J"},{"key":"ref=156","first-page":"3668","volume":"12","author":"Wu S.P.","year":"2019","unstructured":"Wu S.P.; Zhang J.W.; Ma J.J.; Li X.; Qi Y.W.; Yang H.Q.; The role of miR-146a in MPTP treated mice with Parkinson\u2019s disease. Int J Clin Exp Med 2019,12(4),3668-3676","journal-title":"Int J Clin Exp Med"},{"key":"ref=157","author":"Du S.","unstructured":"Du S.; Deng Y.; Yuan H.; Sun Y.; Safflower Yellow B Protects Brain against Cerebral Ischemia Reperfusion Injury through AMPK\/NF-kB Pathway. Evid Based Complement Alternat Med, 2019, 2019"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jsps.2019.04.002","volume":"27","author":"Ansari M.N.","year":"2019","unstructured":"Ansari M.N.; Ganaie M.A.; Rehman N.U.; Alharthy K.M.; Khan T.H.; Imam F.; Ansari M.A.; Al-Harbi N.O.; Jan B.L.; Sheikh I.A.; Hamad A.M.; Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-\u03baB signaling in rats. Saudi Pharm J 2019,27(5),673-681","journal-title":"Saudi Pharm J"},{"key":"ref=159","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/276540","volume":"2013","author":"Wang Y.","year":"2013","unstructured":"Wang Y.; Wang Y.; Yang G.Y.; MicroRNAs in cerebral ischemia. Stroke Res Treat 2013,2013","journal-title":"Stroke Res Treat"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1177\/0963689718806818","volume":"27","author":"Wang S.W.","year":"2018","unstructured":"Wang S.W.; Liu Z.; Shi Z.S.; Non-Coding RNA in acute ischemic stroke: mechanisms, biomarkers and therapeutic targets. Cell Transplant 2018,27(12),1763-1777","journal-title":"Cell Transplant"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3892\/etm.2019.7827","volume":"18","author":"Xiang B.","year":"2019","unstructured":"Xiang B.; Zhong P.; Fang L.; Wu X.; Song Y.; Yuan H.; miR-183 inhibits microglia activation and expression of inflammatory factors in rats with cerebral ischemia reperfusion via NF-\u03baB signaling pathway. Exp Ther Med 2019,18(4),2540-2546","journal-title":"Exp Ther Med"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3892\/mmr.2019.10269","volume":"20","author":"Dong H.","year":"2019","unstructured":"Dong H.; Cui B.; Hao X.; MicroRNA22 alleviates inflammation in ischemic stroke via p38 MAPK pathways. Mol Med Rep 2019,20(1),735-744","journal-title":"Mol Med Rep"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1007\/s11064-017-2372-z","volume":"42","author":"Feng Y.","year":"2017","unstructured":"Feng Y.; Cui C.; Liu X.; Wu Q.; Hu F.; Zhang H.; Ma Z.; Wang L.; Protective role of apocynin via suppression of neuronal autophagy and TLR4\/NF-\u03baB signaling pathway in a rat model of traumatic brain injury. Neurochem Res 2017,42(11),3296-3309","journal-title":"Neurochem Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.arr.2017.02.004","volume":"36","author":"Rahimifard M.","year":"2017","unstructured":"Rahimifard M.; Maqbool F.; Moeini-Nodeh S.; Niaz K.; Abdollahi M.; Braidy N.; Nabavi S.M.; Nabavi S.F.; Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Ageing Res Rev 2017,36,11-19","journal-title":"Ageing Res Rev"},{"key":"ref=165","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.07.022","author":"Shi H.","unstructured":"Shi H.; Hua X.; Kong D.; Stein D.; Hua F.; Role of Toll-like receptor mediated signaling in traumatic brain injury Neuropharmacology, 2019, 145(Pt B), 259-267","journal-title":"Role of Toll-like receptor mediated signaling in traumatic brain injury Neuropharmacology, 2019, 145(Pt B), 259-267"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1089\/neu.2013.3169","volume":"31","author":"Jayakumar A.R.","year":"2014","unstructured":"Jayakumar A.R.; Tong X.Y.; Ruiz-Cordero R.; Bregy A.; Bethea J.R.; Bramlett H.M.; Norenberg M.D.; Activation of NF-\u03baB mediates astrocyte swelling and brain edema in traumatic brain injury. J Neurotrauma 2014,31(14),1249-1257","journal-title":"J Neurotrauma"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","volume":"21","author":"Xiong Y.","year":"2018","unstructured":"Xiong Y.; Mahmood A.; Chopp M.; Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin J Traumatol 2018,21(3),137-151","journal-title":"Chin J Traumatol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3892\/ijmm.2016.2495","volume":"37","author":"Feng Y.","year":"2016","unstructured":"Feng Y.; Cui Y.; Gao J.L.; Li M.H.; Li R.; Jiang X.H.; Tian Y.X.; Wang K.J.; Cui C.M.; Cui J.Z.; Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4\/NF-\u03baB signaling pathway in experimental traumatic brain injury. Int J Mol Med 2016,37(4),921-930","journal-title":"Int J Mol Med"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/08923973.2019.1608560","volume":"41","author":"Kong L.","year":"2019","unstructured":"Kong L.; Yao Y.; Xia Y.; Liang X.; Ni Y.; Yang J.; Osthole alleviates inflammation by down-regulating NF-\u03baB signaling pathway in traumatic brain injury. Immunopharmacol Immunotoxicol 2019,41(2),349-360","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103948","volume":"9","author":"Liu L.","year":"2014","unstructured":"Liu L.; Sun T.; Liu Z.; Chen X.; Zhao L.; Qu G.; Li Q.; Traumatic brain injury dysregulates microRNAs to modulate cell signaling in rat hippocampus. PLoS One 2014,9(8)","journal-title":"PLoS One"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.expneurol.2014.12.018","volume":"265","author":"Wang W.X.","year":"2015","unstructured":"Wang W.X.; Visavadiya N.P.; Pandya J.D.; Nelson P.T.; Sullivan P.G.; Springer J.E.; Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. Exp Neurol 2015,265,84-93","journal-title":"Exp Neurol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s11064-019-02849-7","volume":"44","author":"Su X.","year":"2019","unstructured":"Su X.; Ye Y.; Yang Y.; Zhang K.; Bai W.; Chen H.; Kang E.; Kong C.; He X.; The Effect of SPTLC2 on promoting neuronal apoptosis is alleviated by MiR-124-3p through TLR4 signalling pathway. Neurochem Res 2019,44(9),2113-2122","journal-title":"Neurochem Res"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","volume":"7","author":"Lee B.H.","year":"2010","unstructured":"Lee B.H.; Kim Y.K.; The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig 2010,7(4),231-235","journal-title":"Psychiatry Investig"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.2174\/1381612823666170111141915","volume":"23","author":"Caviedes A.","year":"2017","unstructured":"Caviedes A.; Lafourcade C.; Soto C.; Wyneken U.; BDNF\/NF-\u03baB signaling in the neurobiology of depression. Curr Pharm Des 2017,23(21),3154-3163","journal-title":"Curr Pharm Des"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12974-019-1475-7","volume":"16","author":"Liu C.H.","year":"2019","unstructured":"Liu C.H.; Zhang G.Z.; Li B.; Li M.; Woelfer M.; Walter M.; Wang L.; Role of inflammation in depression relapse. J Neuroinflammation 2019,16(1),90","journal-title":"J Neuroinflammation"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.0910658107","volume":"107","author":"Koo J.W.","year":"2010","unstructured":"Koo J.W.; Russo S.J.; Ferguson D.; Nestler E.J.; Duman R.S.; Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 2010,107(6),2669-2674","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-019-1522-4","volume":"10","author":"Tang C.Z.","year":"2019","unstructured":"Tang C.Z.; Zhang D.F.; Yang J.T.; Liu Q.H.; Wang Y.R.; Wang W.S.; Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-\u03baB signaling pathway. Cell Death Dis 2019,10(4),316","journal-title":"Cell Death Dis"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cells8070647","volume":"8","author":"Hung Y.Y.","year":"2019","unstructured":"Hung Y.Y.; Wu M.K.; Tsai M.C.; Huang Y.L.; Kang H.Y.; Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 correlates with severity of depression in patients with major depressive disorder and is ameliorated after antidepressant treatment. Cells 2019,8(7),647","journal-title":"Cells"},{"key":"ref=179","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.06.015","volume":"1720","author":"Feng J.","year":"2019","unstructured":"Feng J.; Wang M.; Li M.; Yang J.; Jia J.; Liu L.; Zhou J.; Zhang C.; Wang X.; Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients. Brain Res 2019,1720","journal-title":"Brain Res"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"Vezzani A.","year":"2013","unstructured":"Vezzani A.; Aronica E.; Mazarati A.; Pittman Q.J.; Epilepsy and brain inflammation. Exp Neurol 2013,244,11-21","journal-title":"Exp Neurol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","volume":"15","author":"Rana A.","year":"2018","unstructured":"Rana A.; Musto A.E.; The role of inflammation in the development of epilepsy. J Neuroinflammation 2018,15(1),144","journal-title":"J Neuroinflammation"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.seizure.2010.12.005","volume":"20","author":"Li G.","year":"2011","unstructured":"Li G.; Bauer S.; Nowak M.; Norwood B.; Tackenberg B.; Rosenow F.; Knake S.; Oertel W.H.; Hamer H.M.; Cytokines and epilepsy. Seizure 2011,20(3),249-256","journal-title":"Seizure"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","volume":"62","author":"Rowley S.","year":"2013","unstructured":"Rowley S.; Patel M.; Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic Biol Med 2013,62,121-131","journal-title":"Free Radic Biol Med"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"Vezzani A.","year":"2011","unstructured":"Vezzani A.; French J.; Bartfai T.; Baram T.Z.; The role of inflammation in epilepsy. Nat Rev Neurol 2011,7(1),31-40","journal-title":"Nat Rev Neurol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","volume":"36","author":"Devinsky O.","year":"2013","unstructured":"Devinsky O.; Vezzani A.; Najjar S.; De Lanerolle N.C.; Rogawski M.A.; Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013,36(3),174-184","journal-title":"Trends Neurosci"},{"key":"ref=186","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/901902","volume":"2014","author":"Shimada T.","year":"2014","unstructured":"Shimada T.; Takemiya T.; Sugiura H.; Yamagata K.; Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm 2014,2014","journal-title":"Mediators Inflamm"},{"key":"ref=187","author":"Somade O.T.","unstructured":"Somade O.T.; Ajayi B.O.; Adeyi O.E.; Aina B.O.; David B. O.; Sodiya I.D.; Activation of NF-kB mediates up-regulation of cerebellar and hypothalamic pro-inflammatory chemokines (RANTES and MCP-1) and cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) in acute edible camphor administration. Sci. Am., 2019, 5e00114."},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1460-9568.2010.07122.x","volume":"31","author":"Aronica E.","year":"2010","unstructured":"Aronica E.; Fluiter K.; Iyer A.; Zurolo E.; Vreijling J.; van Vliet E.A.; Baayen J.C.; Gorter J.A.; Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010,31(6),1100-1107","journal-title":"Eur J Neurosci"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2013.09.049","volume":"1584","author":"Li M.M.","year":"2014","unstructured":"Li M.M.; Li X.M.; Zheng X.P.; Yu J.T.; Tan L.; MicroRNAs dysregulation in epilepsy. Brain Res 2014,1584,94-104","journal-title":"Brain Res"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.2174\/1871527314666150317225945","volume":"14","author":"Alsharafi W.","year":"2015","unstructured":"Alsharafi W.; Xiao B.; Dynamic expression of microRNAs (183, 135a, 125b, 128, 30c and 27a) in the rat pilocarpine model and temporal lobe epilepsy patients. CNS Neurol Disord Drug Targets 2015,14(8),1096-1102","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/S1474-4422(16)30246-0","volume":"15","author":"Henshall D.C.","year":"2016","unstructured":"Henshall D.C.; Hamer H.M.; Pasterkamp R.J.; Goldstein D.B.; Kjems J.; Prehn J.H.M.; Schorge S.; Lamottke K.; Rosenow F.; MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol 2016,15(13),1368-1376","journal-title":"Lancet Neurol"},{"key":"ref=192","first-page":"3479","volume":"22","author":"Huang W.S.","year":"2018","unstructured":"Huang W.S.; Zhu L.; MiR-134 expression and changes in inflammatory cytokines of rats with epileptic seizures. Eur Rev Med Pharmacol Sci 2018,22(11),3479-3484","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/08830180903208303","volume":"28","author":"Sonkoly E.","year":"2009","unstructured":"Sonkoly E.; Pivarcsi A.; microRNAs in inflammation. Int Rev Immunol 2009,28(6),535-561","journal-title":"Int Rev Immunol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.exger.2014.03.002","volume":"56","author":"Rippo M.R.","year":"2014","unstructured":"Rippo M.R.; Olivieri F.; Monsurr\u00f2 V.; Prattichizzo F.; Albertini M.C.; Procopio A.D.; MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a. Exp Gerontol 2014,56,154-163","journal-title":"Exp Gerontol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.abb.2016.06.001","volume":"604","author":"Hai Ping","year":"2016","unstructured":"Hai Ping; P.; Feng Bo, T.; Li, L.; Nan, H. Y.; Hong, Z. IL-1\u03b2\/NF-kb signaling promotes colorectal cancer cell growth through miR-181a\/PTEN axis. Arch Biochem Biophys 2016,604,20-26","journal-title":"Arch Biochem Biophys"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2015.10.023","volume":"452","author":"Srivastava A.","year":"2016","unstructured":"Srivastava A.; Dixit A.B.; Banerjee J.; Tripathi M.; Sarat Chandra P.; Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy. Clin Chim Acta 2016,452,1-9","journal-title":"Clin Chim Acta"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.05.004","volume":"132","author":"Liu A.H.","year":"2017","unstructured":"Liu A.H.; Wu Y.T.; Wang Y.P.; MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4\/NF-kB signaling pathway. Brain Res Bull 2017,132,139-149","journal-title":"Brain Res Bull"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1517\/14728222.2014.989834","volume":"19","author":"Srinivasan M.","year":"2015","unstructured":"Srinivasan M.; Lahiri D.K.; Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer\u2019s disease and multiple sclerosis. Expert Opin Ther Targets 2015,19(4),471-487","journal-title":"Expert Opin Ther Targets"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fnmol.2015.00024","volume":"8","author":"Karunaweera N.","year":"2015","unstructured":"Karunaweera N.; Raju R.; Gyengesi E.; M\u00fcnch G.; Plant polyphenols as inhibitors of NF-\u03baB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer\u2019s disease? Front Mol Neurosci 2015,8,24","journal-title":"Front Mol Neurosci"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2017.11.030","volume":"129","author":"Seo E.J.","year":"2018","unstructured":"Seo E.J.; Fischer N.; Efferth T.; Phytochemicals as inhibitors of NF-\u03baB for treatment of Alzheimer\u2019s disease. Pharmacol Res 2018,129,262-273","journal-title":"Pharmacol Res"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"Santa-Cec\u00edlia F.V.","year":"2016","unstructured":"Santa-Cec\u00edlia F.V.; Socias B.; Ouidja M.O.; Sepulveda-Diaz J.E.; Acu\u00f1a L.; Silva R.L.; Michel P.P.; Del-Bel E.; Cunha T.M.; Raisman-Vozari R.; Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox Res 2016,29(4),447-459","journal-title":"Neurotox Res"},{"key":"ref=202","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169560","volume":"12","author":"Jing H.","year":"2017","unstructured":"Jing H.; Wang S.; Wang M.; Fu W.; Zhang C.; Xu D.; Isobavachalcone attenuates mptp-induced Parkinson\u2019s Disease in mice by inhibition of microglial activation through NF-\u03baB pathway. PLoS One 2017,12(1)","journal-title":"PLoS One"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/cells8020194","volume":"8","author":"Subedi L.","year":"2019","unstructured":"Subedi L.; Lee J.H.; Yumnam S.; Ji E.; Kim S.Y.; Anti-inflammatory effect of sulforaphane on lps-activated microglia potentially through JNK\/AP-1\/NF-\u03baB inhibition and Nrf2\/HO-1 Activation. Cells 2019,8(2),194","journal-title":"Cells"},{"key":"ref=204","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109371","volume":"133","author":"Majdi F.","year":"2019","unstructured":"Majdi F.; Taheri F.; Salehi P.; Motaghinejad M.; Safari S.; Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-\u03baB signaling. Med Hypotheses 2019,133","journal-title":"Med Hypotheses"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/1570159X14666160120152423","volume":"14","author":"Lu H.","year":"2016","unstructured":"Lu H.; Le W.D.; Xie Y.Y.; Wang X.P.; Current therapy of drugs in amyotrophic lateral sclerosis. Curr Neuropharmacol 2016,14(4),314-321","journal-title":"Curr Neuropharmacol"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s12035-017-0532-4","volume":"55","author":"Crisafulli S.G.","year":"2018","unstructured":"Crisafulli S.G.; Brajkovic S.; Cipolat Mis M.S.; Parente V.; Corti S.; Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol 2018,55(4),2789-2813","journal-title":"Mol Neurobiol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11481-019-09866-x","volume":"14","author":"Zhao Z.","year":"2019","unstructured":"Zhao Z.; Fu J.; Li S.; Li Z.; Neuroprotective effects of genistein in a sod1-g93a transgenic mouse model of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 2019,14(4),688-696","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=208","first-page":"110","volume":"13","author":"Yun Y.C.","year":"2019","unstructured":"Yun Y.C.; Jeong S.G.; Kim S.H.; Cho G.W.; Reduced sirtuin 1\/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J Tissue Eng Regen Med 2019,13(1),110-115","journal-title":"J Tissue Eng Regen Med"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neures.2008.05.004","volume":"62","author":"Bai Y.","year":"2008","unstructured":"Bai Y.; Li Q.; Yang J.; Zhou X.; Yin X.; Zhao D.; p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Neurosci Res 2008,62(1),9-14","journal-title":"Neurosci Res"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13258-018-00781-8","volume":"41","author":"Choi J.","year":"2019","unstructured":"Choi J.; Kim J.; Min D.Y.; Jung E.; Lim Y.; Shin S.Y.; Lee Y.H.; Inhibition of TNF\u03b1-induced interleukin-6 gene expression by barley (Hordeum vulgare) ethanol extract in BV-2 microglia. Genes Genomics 2019,41(5),557-566","journal-title":"Genes Genomics"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.brainresbull.2018.08.021","volume":"142","author":"Zhang L.","year":"2018","unstructured":"Zhang L.; Previn R.; Lu L.; Liao R.F.; Jin Y.; Wang R.K.; Crocin, a natural product attenuates lipopolysaccharide-induced anxiety and depressive-like behaviors through suppressing NF-kB and NLRP3 signaling pathway. Brain Res Bull 2018,142,352-359","journal-title":"Brain Res Bull"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/ptr.6340","volume":"33","author":"Yu H.","year":"2019","unstructured":"Yu H.; Zhang F.; Guan X.; Baicalin reverse depressive-like behaviors through regulation SIRT1-NF-kB signaling pathway in olfactory bulbectomized rats. Phytother Res 2019,33(5),1480-1489","journal-title":"Phytother Res"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/CMAR.S186696","volume":"11","author":"El-Agamy D.S.","year":"2018","unstructured":"El-Agamy D.S.; El-Harbi K.M.; Khoshhal S.; Ahmed N.; Elkablawy M.A.; Shaaban A.A.; Abo-Haded H.M.; Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways. Cancer Manag Res 2018,11,47-61","journal-title":"Cancer Manag Res"},{"key":"ref=214","first-page":"660","volume":"17","author":"Zhu S.","year":"2018","unstructured":"Zhu S.; Tang S.; Su F.; Dioscin inhibits ischemic strokeinduced inflammation through inhibition of the TLR4\/MyD88\/NF\u03baB signaling pathway in a rat model. Mol Med Rep 2018,17(1),660-666","journal-title":"Mol Med Rep"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yexcr.2018.05.012","volume":"369","author":"Sun X.","year":"2018","unstructured":"Sun X.; Zeng H.; Wang Q.; Yu Q.; Wu J.; Feng Y.; Deng P.; Zhang H.; Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway. Exp Cell Res 2018,369(1),112-119","journal-title":"Exp Cell Res"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"322","DOI":"10.37290\/ctnr2641-452X.17:322-328","volume":"17","author":"Luan L.","year":"2019","unstructured":"Luan L.; Cao L.; Zhu L.; Sun J.; Diosmetin ameliorates cerebral ischemia\/reperfusion injury in pc12 cells through nuclear factor-kB (NF-kB) and nuclear factor erythroid 2-related factor\/heme oxygenase-1 (Nrf 2\/HO-1) Pathway. Curr Top Nutraceutical Res 2019,17(3),322-328","journal-title":"Curr Top Nutraceutical Res"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.1096\/fj.201900326R","volume":"33","author":"Nan D.","year":"2019","unstructured":"Nan D.; Jin H.; Deng J.; Yu W.; Liu R.; Sun W.; Huang Y.; Cilostazol ameliorates ischemia\/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress. FASEB J 2019,33(9),10152-10164","journal-title":"FASEB J"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fneur.2018.00590","volume":"9","author":"Gugliandolo E.","year":"2018","unstructured":"Gugliandolo E.; D\u2019Amico R.; Cordaro M.; Fusco R.; Siracusa R.; Crupi R.; Impellizzeri D.; Cuzzocrea S.; Di Paola R.; Neuroprotective effect of artesunate in experimental model of traumatic brain injury. Front Neurol 2018,9,590","journal-title":"Front Neurol"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2018.03.020","volume":"140","author":"Dai W.","year":"2018","unstructured":"Dai W.; Wang H.; Fang J.; Zhu Y.; Zhou J.; Wang X.; Zhou Y.; Zhou M.; Curcumin provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway. Brain Res Bull 2018,140,65-71","journal-title":"Brain Res Bull"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11033-018-4465-4","volume":"46","author":"Caglayan B.","year":"2019","unstructured":"Caglayan B.; Kilic E.; Dalay A.; Altunay S.; Tuzcu M.; Erten F.; Orhan C.; Gunal M.Y.; Yulug B.; Juturu V.; Sahin K.; Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2\/HO-1 and NF-\u03baB pathways in traumatic brain injury in mice. Mol Biol Rep 2019,46(1),241-250","journal-title":"Mol Biol Rep"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"285a","DOI":"10.1016\/j.bpj.2017.11.1638","volume":"114","author":"Vigont V.","year":"2018","unstructured":"Vigont V.; Gusev K.; Kaznacheyeva E.; EVP4593 Compound Decreases abnormal store-operated calcium entry in ipscs-based model of Huntington\u2019s Disease. Biophysical 2018,114(3),285a-286a","journal-title":"Biophysical"},{"key":"ref=222","author":"Wickenberg A.K.","unstructured":"Wickenberg A.K.; Hagai E.L.; Eyal E.; +Teva Pharmaceutical Industries Ltd, assignee. Use of laquinimod to delay huntington's disease progression. United States patent application US 15\/794,846"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12041-018-0957-1","volume":"97","author":"Pandey M.","year":"2018","unstructured":"Pandey M.; Rajamma U.; Huntington\u2019s disease: the coming of age. J Genet 2018,97(3),649-664","journal-title":"J Genet"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.parkreldis.2018.12.003","volume":"59","author":"Mestre T.A.","year":"2019","unstructured":"Mestre T.A.; Recent advances in the therapeutic development for Huntington disease. Parkinsonism Relat Disord 2019,59,125-130","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41380-018-0021-9","volume":"24","author":"Denis H.L.","year":"2019","unstructured":"Denis H.L.; Lauruol F.; Cicchetti F.; Are immunotherapies for Huntington\u2019s disease a realistic option? Mol Psychiatry 2019,24(3),364-377","journal-title":"Mol Psychiatry"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2174\/1568026618666180711153416","volume":"18","author":"Kataria R.","year":"2018","unstructured":"Kataria R.; Sobarzo-Sanchez E.; Khatkar A.; Role of morin in neurodegenerative diseases: a review. Curr Top Med Chem 2018,18(11),901-907","journal-title":"Curr Top Med Chem"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainres.2010.03.069","volume":"1338","author":"Provost P.","year":"2010","unstructured":"Provost P.; MicroRNAs as a molecular basis for mental retardation, Alzheimer\u2019s and prion diseases. Brain Res 2010,1338,58-66","journal-title":"Brain Res"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.expneurol.2011.09.003","volume":"235","author":"Satoh J.","year":"2012","unstructured":"Satoh J.; Molecular network of microRNA targets in Alzheimer\u2019s disease brains. Exp Neurol 2012,235(2),436-446","journal-title":"Exp Neurol"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3892\/mmr.2016.5759","volume":"14","author":"da Silva F.C.","year":"2016","unstructured":"da Silva F.C.; Iop R.D.; Vietta G.G.; Kair D.A.; Gutierres Filho P.J.; de Alvarenga J.G.; da Silva R.; microRNAs involved in Parkinson\u2019s disease: A systematic review. Mol Med Rep 2016,14(5),4015-4022","journal-title":"Mol Med Rep"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3940(98)00158-X","volume":"244","author":"Nagai M.","year":"1998","unstructured":"Nagai M.; Abe K.; Okamoto K.; Itoyama Y.; Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998,244(3),165-168","journal-title":"Neurosci Lett"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/8091","volume":"2","author":"Trotti D.","year":"1999","unstructured":"Trotti D.; Rolfs A.; Danbolt N.C.; Brown R.H.; Hediger M.A.; SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 1999,2(5),427-433","journal-title":"Nat Neurosci"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-8-28","volume":"8","author":"Chen S.","year":"2013","unstructured":"Chen S.; Sayana P.; Zhang X.; Le W.; Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 2013,8(1),28","journal-title":"Mol Neurodegener"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/0004-282X20140229","volume":"73","author":"Souza P.V.","year":"2015","unstructured":"Souza P.V.; Pinto W.B.; Oliveira A.S.; C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases. Arq Neuropsiquiatr 2015,73(3),246-256","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0169-328X(95)00175-R","volume":"34","author":"Krasemann S.","year":"1995","unstructured":"Krasemann S.; Zerr I.; Weber T.; Poser S.; Kretzschmar H.; Hunsmann G.; Bodemer W.; Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Brain Res Mol Brain Res 1995,34(1),173-176","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0378-1119(96)00600-2","volume":"184","author":"Baybutt H.","year":"1997","unstructured":"Baybutt H.; Manson J.; Characterisation of two promoters for prion protein (PrP) gene expression in neuronal cells. Gene 1997,184(1),125-131","journal-title":"Gene"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/AJP.0000000000000260","volume":"32","author":"Boakye P.A.","year":"2016","unstructured":"Boakye P.A.; Olechowski C.; Rashiq S.; Verrier M.J.; Kerr B.; Witmans M.; Baker G.; Joyce A.; Dick B.D.; A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain 2016,32(4),327-336","journal-title":"Clin J Pain"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2017.12.011","volume":"112","author":"Burak K.","year":"2018","unstructured":"Burak K.; Lamoureux L.; Boese A.; Majer A.; Saba R.; Niu Y.; Frost K.; Booth S.A.; MicroRNA-16 targets mRNA involved in neurite extension and branching in hippocampal neurons during presymptomatic prion disease. Neurobiol Dis 2018,112,1-13","journal-title":"Neurobiol Dis"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/179127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/179127\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/179127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T08:01:10Z","timestamp":1695715270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/179127\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":237,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200207120949","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}